BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//7RZMUE
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-7RZMUE@sciencenext.org
DTSTART;TZID=EET:20260910T170000
DTEND;TZID=EET:20260910T173000
DESCRIPTION:<p style="margin-left: 0px!important\;">Purpose: Present surgic
 al techniques for converting percutaneous (PC) to transcutaneous (TC) BCD 
 devices and for electrode placement in revision CI cases.</p><p style="mar
 gin-left: 0px!important\;">Methods: We reviewed 16 patients converting PC 
 to a TC &nbsp\;BCD and 18 revision CI cases in our single implant center O
 ctober1\, 2023-July 30\, 2026.</p><p style="margin-left: 0px!important\;">
 Results: &nbsp\;Reasons for converting to TC BCD included extruded the abu
 tment/fixture from persistent granulation tissue with superficial infectio
 n\, skin breakdown\, chronic recurring granulation tissue around the abutm
 ent and elective change to a TC device. The CI group included revisions fo
 r device malfunction\, delayed infection\, basal turn ossification\, and u
 nexpected cochlear duct soft tissue obstruction. Scalp flap revision and m
 anagement of internal device components are reviewed in video and pictoria
 l formats. In the CI cases\, the use of SMART-Nav intraoperatively was use
 d to verify electrode placement after revision. Wound complications\, faci
 al nerve stimulation\, balance issues\, and comparison to prior performanc
 e will be presented. Pedicled scalp rotation flap design\, antibiotic util
 ization and implanted fixture assessment will be discussed.</p><p style="m
 argin-left: 0px!important\;">Conclusion: Common principles for managing th
 e soft tissue of the scalp when revising BCD and CI will be presented in a
 n interactive format. Managing implanted fixtures and CI electrodes will b
 e addressed separately with emphasis on optimizing postop healing and audi
 tory performance.</p>
DTSTAMP:20260805T021754Z
LOCATION:Hearing Aids
SUMMARY:Revising implantable hearing devices: Principes for converting a pe
 rcutaneous to transcutaneous Bone Conducting - Douglas D. Backous\, Bülen
 t Gündüz
URL:https://sciencenext.org/ifos2026/talk/7RZMUE/
END:VEVENT
END:VCALENDAR